Evaxion Biotech AS
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $22 | $7,492 | $37 |
Gross Profit | -7,529 | 7,492 | 37 | |
EBITDA | -3,833 | -8,285 | 5,712 | -4,785 |
EBIT | -8,814 | 3,023 | ||
Net Income | -3,642 | -5,918 | 4,618 | -4,831 |
Net Change In Cash | 0 | 22 | 7,492 | 37 |
Free Cash Flow | -6,656 | |||
Cash | 18,440 | 23,233 | 10,572 | 14,746 |
Basic Shares | 8,340 | 6,408 | 1,105 | 1,105 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,528 | $3,344 | $73 | $0 |
Gross Profit | 7,528 | 3,344 | 73 | -571 |
EBITDA | -7,124 | -9,786 | -21,403 | -22,572 |
EBIT | -7,739 | -10,393 | -22,018 | -23,143 |
Net Income | -7,707 | -10,567 | -22,125 | -23,169 |
Net Change In Cash | 7,528 | 3,344 | 73 | 0 |
Free Cash Flow | -6,656 | -12,940 | -17,778 | -26,066 |
Cash | 23,233 | 5,052 | 5,583 | 13,184 |
Basic Shares | 6,408 | 1,072 | 683 | 590 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.01 |
2025-12-31 | -$0.01 |
2025-09-30 | $0.50 |
2025-06-30 | -$1 |